Oras Medical Launches Free Aesthetic Ultrasound Investment Checklist to Help Clinics Make Better Technology Decisions

Oras Medical has launched a new Aesthetic Ultrasound Investment Checklist, a free decision-support resource designed to help aesthetic practitioners and clinic owners assess whether ultrasound is the right investment for their practice before committing thousands of pounds to new technology.

“The Aesthetic Ultrasound Investment Checklist – 12 Questions to Answer Before Investing £5,000+ in Ultrasound,” the resource encourages clinics to look beyond scanner specifications and consider the wider clinical, operational and financial factors that determine whether ultrasound will be successfully adopted.

The growing use of ultrasound within aesthetic medicine is creating new opportunities for practitioners to visualise anatomy, identify vascular structures, locate previously placed filler and support more informed clinical decision-making.

However, Oras Medical believes purchasing the technology is only one part of successful adoption.

“Clinics can understandably become focused on choosing the right scanner, but the bigger question is whether they are actually ready to integrate ultrasound successfully into their practice,” said Jeffrey Oravbiere, Founder of Oras Medical.

“Before investing £5,000 or more, a clinic should understand exactly how ultrasound will be used, who will use it, what training is required, how it will fit into existing workflows and whether there is sufficient clinical utilisation to justify the investment.”

The checklist has therefore been developed around practical questions that clinic owners should consider before purchasing ultrasound equipment.

These include identifying clear clinical use cases, evaluating practitioner capability and training requirements, considering workflow integration, assessing likely utilisation and understanding the wider requirements involved in introducing ultrasound into clinical practice.

The resource forms part of Oras Medical's wider approach to technology adoption, which focuses on helping healthcare professionals move from technology interest to informed investment and sustainable clinical adoption.

Oras Medical is also developing this approach through its Portable Diagnostic Device Adoption Framework (PDDAF), which examines the organisational, operational, clinical and supply chain factors that can influence whether portable diagnostic technologies are successfully implemented.

Building on the free checklist, Oras Medical has developed its Aesthetic Ultrasound Investment & Adoption Blueprint, a personalised decision-support service for clinics actively considering ultrasound.

Rather than recommending a scanner immediately, the Blueprint evaluates the individual clinic's circumstances and provides a structured assessment covering areas such as clinic suitability, clinical use cases, capability and training, technology requirements, investment and utilisation, adoption risks, workflow integration and a 90-day adoption roadmap.

“The objective isn't to convince every clinic to buy ultrasound,” added Oravbiere. “It's to help clinics make a better decision about whether — and how — to adopt it. Sometimes the right decision may be to invest now, while for another clinic it may be better to address capability, training or utilisation first.”

The initiative reflects a broader shift in Oras Medical's strategy from simply supplying portable diagnostic equipment towards supporting the complete technology adoption journey.

Through devices, education, onboarding and implementation support, Oras Medical aims to help clinicians adopt portable diagnostics for faster, safer decisions at the point of care.

About Oras Medical

Oras Medical is a UK healthcare technology adoption company specialising in portable diagnostic technologies, including ultrasound and bladder scanning solutions.

The company supports healthcare professionals and organisations through technology selection, education, clinical onboarding and adoption support, helping ensure that investment in diagnostic technology translates into meaningful and sustainable clinical use.